Antigen-specific T cells are important sources of interferon (IFN)-
to B. pseudomallei is found in the majority of children living in areas where the organism is endemic [3] , it is not known what immune mechanisms or defects confer resistance versus susceptibility to active disease. B. pseudomallei is classified as a class B potential agent for biological warfare and terrorism. A better understanding of immune responses to B. pseudomallei is needed for the generation of a novel vaccine or immunotherapeutic approaches for melioidosis.
B. pseudomallei is a facultative intracellular pathogen that, like Listeria monocytogenes, resides in the host cell cytosol after lysis of the phagosome [4, 5] . Individuals with severe melioidosis have elevated concentrations of many serum cytokines, such as interferon (IFN)-g, interleukin (IL)-12, and IL-18 [6] , and restimulation of peripheral blood mononuclear cells from recovering patients generates an antigen-specific IFN-g immune response to B. pseudomallei [7] . We and others have developed mouse models to study the immunological mechanisms of protection against B. pseudomallei [4, [8] [9] [10] . Using cytokine neutralizing monoclonal anti- bodies (MAbs), we have shown that IFN-g is essential for resistance to B. pseudomallei [9] . These clinical and experimental observations indicates that B. pseudomallei is a potent activator of cell-mediated immunity; but, to date, the in vivo source(s) of IFN-g and the role of T cells in resistance to infection have not been defined.
In other models of primary infection, multiple cell types produce IFN-g [11] [12] [13] [14] . NK cells, NK T cells, and macrophages can contribute to early resistance through IFN-g production [15] [16] [17] . Antigen-specific T cells play well-documented roles in IFN-g-dependent protection against intracellular pathogens [18] [19] [20] . However, there is growing evidence that conventional T cell receptor (TCR) a/b + CD4 + and CD8 + T cells can also produce IFN-g in the absence of cognate antigen in response to IL-12 and IL-18 [21] [22] [23] [24] [25] . However, the relative importance in vivo of these 2 pathways of T cell activation has not previously been examined in any model of infection. We previously demonstrated that B. pseudomallei and L. monocytogenes stimulate T cells (and NK cells) to produce IFN-g in an IL-12-and IL-18-dependent manner in vitro [23] . We investigated cytokine-mediated T cell (and NK cell) production of IFN-g in vivo after B. pseudomallei infection and determined its importance for the initial control of bacterial growth. In addition, we tested the hypothesis that antigen-specific T cells may be detected later during infection and whether they contribute to resistance against primary melioidosis.
MATERIALS AND METHODS
Bacterial strains and culture conditions. B. pseudomallei strain 576, isolated from a patient with melioidosis in Thailand, was obtained from Ty Pitt (Health Protection Agency, London, UK) [26] [27] [28] . Bacteria were cultured in tryptone soy (TS) broth or TS agar. Bacteria were grown statically for 24-48 h at 37ЊC, collected by centrifugation, washed in PBS, and frozen at Ϫ80ЊC in PBS that contained 30% glycerol. Dead B. pseudomallei strain 576 organisms were prepared by g-irradiation (6500 Gy) of 30% glycerol stocks. Once they were confirmed as nonviable by plating, bacteria were washed, resuspended in RPMI 1640 medium (Sigma), and stored at Ϫ80ЊC. All procedures using live bacteria were performed under Advisory Committee on Dangerous Pathogens category 3 containment.
Mice. Antibodies and in vivo cell depletion. Anti-CD4 (YTS191) and anti-CD8 (YTS169) MAbs and isotype control Mac-5 antibodies were obtained from Roman Lukaszewski (Defence Science and Technology Laboratory, Salisbury, UK). Mice were administered 500 mg of MAb intraperitoneally (ip) 4 days before infection and 250 mg 1 day before infection. Depletion was maintained by further administration of 250 mg of MAb every 3 days after infection. NK cells were depleted by the intravenous (iv) injection of 25-30 mL of rabbit anti-asialoGM1 polyclonal antibody per mouse (endotoxin levels, 380 ng/mL; Cedarlane Labs) 1 day before infection. The efficiency of depletions in the spleen at the time of infection and time points thereafter was 199% for CD4 + T cells with YTS191, 197% for CD8 + cells with YTS169, and 198% for NK cells with anti-asialoGM1, as verified by flow-cytometric analysis of splenocytes with noncompeting anti-CD4 MAb RM4-5, anti-CD8 MAb 53-6.7, and anti-NK1.1 (BD Biosciences). Macrophages were depleted by iv administration of clodronate liposomes. The efficiency of splenic F4/80 + macrophage depletion was 199% at day 3 after treatment and 190% at day 7 after treatment. [29, 30] . Clodronate was a gift from Roche Diagnostics. Clodronate liposomes were prepared as described elsewhere [30] . The MAbs anti-b-galactosidase (isotype control, GL117), anti-IL-12 (C17.8; provided by Helena Helmby, Department of Infectious and Tropical Diseases, LSHTM, and originally obtained from G. Trinchieri, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland [31] ), and anti-IL-18 receptor (R) (TC30-28E3; provided by Anne O'Garra, National Institute for Medical Research, London, UK, and originally produced at DNAX Research Institute, Palo Alto, CA [32] ), were administered (1 mg) ip 6 h before infection.
Infection of mice. Bacteria were thawed, diluted in PBS, and administered ip (0.2 mL). For each infection, the inoculum was plated onto TS agar plates to confirm the inoculation dose.
Determination of organ bacterial burden. Spleens were aseptically removed and homogenized in sterile PBS or RPMI 1640 (Sigma) by passing them through 70-mm cell strainers, using a syringe plunger. Dilutions of tissue homogenates were plated onto TS agar and incubated at 37ЊC; colonies were enumerated after 24 h.
Preparation and stimulation of murine splenocytes in vitro. Spleens were removed aseptically, and splenocyte suspensions were produced by passing them through sterile 70-mm cell strainers. Erythrocytes were lysed, and cells were washed and Flow-cytometric analysis for cell-surface marker and intracellular IFN-g staining. Cells intended for intracellular IFNg staining were treated with brefeldin A (10 mg/mL; Sigma) for 3 h. Cells were washed in 1% FCS-PBS, and nonspecific antibody binding was blocked with anti-CD16/32 (1mg/mL, 2.4G2; BD Biosciences). MAbs used for cell-surface staining were fluorescein isothiocyanate (FITC)-anti-CD4 (RM4-5), FITC-anti-CD8 (53-6.7), FITC-anti-7/4, FITC-anti-CD11b (M1/70.15) (Caltag Laboratories), phycoerythrin (PE)-anti-NK1.1 (PK136), PE-anti-CD49b (DX5), PE-anti-Gr1 (RB6-8C5), PE-anti-F4/ 80, FITC-0 and peridinin-chlorophyll-protein-anti-CD3 (145-2C11), and allophycocyanin (APC)-anti-CD11c (HL3) (BD Biosciences). Cells were stained with antibodies, washed twice, and fixed for 20 min in 2% paraformaldehyde. Cells were permeabilized in 0.1% saponin-1% FCS-PBS, incubated with APC-or PE-anti-IFN-g (0.5 mg/tube) (XMG1.2; BD Biosciences), washed twice, and fixed overnight in 2% paraformaldehyde. Cells were analyzed using a FACScalibur instrument with CellQuest software (version 3.3; BD Biosciences) under category 3 aerosol biocontainment.
Statistical analysis. Survival curves were compared using log rank Kaplan-Meier tests. Student's t test was used for all other statistical tests.
was considered to be statistically P ! .05 significant.
RESULTS

Necessity of IFN-g, IL-12
, and IL-18 for protection against primary B. pseudomallei infection. C57BL/6 mice are relatively resistant to B. pseudomallei ip infection [4, 8] , which results in rapid phagocytosis and transport of bacteria to the spleen [33, 34] , so this was chosen as an appropriate route for the assessment of resistance to B. pseudomallei infection. Infection with cfu of B. pseudomallei strain 576 per mouse 6 1 ϫ 10 did not result in any deaths within the first 20 days of infection. C57BL/6 mice cleared most bacteria from the spleen within the first few days of an ip infection, but they ultimately died and had abscesses that contained B. pseudomallei in multiple organs. The natural resistance of C57BL/6 mice made them a suitable model for the study of mechanisms of host resistance to primary B. pseudomallei infection.
To identify host factors controlling initial resistance, C57BL/ 6 or isogenic IFN-g Functional redundancy of T cell-and NK cell-derived IFNg for initial control of B. pseudomallei infection. To define the contribution of each IFN-g-producing cell type to resistance, we studied bacterial clearance from the spleens of mice after the depletion of IFN-g, T cell subsets, or NK cells. C57BL/6 mice had bacteria in their spleens at day 1 4 1 ϫ 10 after infection; this decreased to 100 bacteria by day 3 ( figure  4A ). As was predicted by the in vivo survival data (figure 1), IFN-g Ϫ/Ϫ mice were unable to control bacterial replication, having 100-fold more bacteria in their spleens by day 1, and all of them died of infection by day 2 ( figure 4A ). In contrast, T and B cell-deficient rag1 Ϫ/Ϫ mice, which had been depleted of both CD4 + (199% depletion) and CD8 + (197% depletion) T cells by MAbs, and NK cell-depleted (with antiasialoGM1; 198% depletion) mice were as proficient as C57BL/ 6 mice at controlling bacterial growth in the spleen ( figure 4B  and 4C) . Surprisingly, the combined depletion of both T cells (197% depletion) and NK cells (199% depletion by antiasialoGM1 treatment of rag1 Ϫ/Ϫ mice) also had no effect on the efficiency of bacterial clearance at 48 h after infection (figure 5A). The determination of IFN-g responses at 16 h after infection revealed a 76% reduction in total IFN-g-producing splenocytes after NK cell depletion in C57BL/6 mice (figure 5B), which is consistent with the frequency of these cells determined by direct assay in figure 2B . NK cell depletion of rag1 Ϫ/Ϫ mice reduced the IFN-g response by 95% ( figure 5B ).
Therefore, although IFN-g production is essential for preventing rapid death, there is extensive redundancy in the source of this cytokine, and as little as 5% of this response is sufficient to provide initial control of B. pseudomallei replication in vivo.
Macrophage production of IFN-g after infection with B. pseudomallei. Despite the elimination of both NK cells and T cells, anti-asialoGM1-treated rag1
Ϫ/Ϫ mice expressed low but detectable numbers of NK1.1 Ϫ IFN-g-producing cells ( figure   5B and data not shown), which suggests that IFN-g production by nonlymphoid cells might compensate for the loss of T cells and NK cells in these mice. figure 6A ). In contrast, we observed no IFN-g production by MHC class II hi dendritic cells (DCs) (figure 6A) or any cells expressing CD11c, CD11b, or Gr1 (data not shown). The treatment of rag1 Ϫ/Ϫ mice with clodronate-containing liposomes 7 Taken together, these data suggest that B. pseudomallei infection stimulates macrophages to produce IFN-g in vivo and that, in the absence of macrophages, the efficiency of IFN-g production by NK cells is substantially reduced.
Protective role of T cells during the later phase of B. pseudomallei infection. Although T cells were dispensable for the initial control of B. pseudomallei, we investigated their role during later stages of infection. rag1 Ϫ/Ϫ mice, which lack B and T cells, died of infection more rapidly (MST, 13 days) than did wild-type mice (MST, 26 days; ) ( figure 7A ). In con-P p .002 trast, mMT mice, which lack B cells, were as susceptible as wildtype mice, which indicates that B cells are not essential for primary resistance ( figure 7B) To test whether infection with B. pseudomallei primes antigen-specific T cells, splenocytes from C57BL/6 mice, obtained 10 days after infection, were restimulated in vitro with killed B. pseudomallei (1 bacterium/10 splenocytes) and analyzed for IFN-g production. An IFN-g response to dead bacteria was observed in splenocytes from infected but not uninfected mice, with CD4 + and CD8 + T cells producing IFN-g ( figure 8 ). The majority of this IFN-g response was inhibited by the addition of cyclosporin A (figure 8), which blocks TCR-mediated but not cytokine receptor-mediated T cell activation [35] . Taken together, these data indicate that primary infection with B. pseudomallei primes populations of antigen-specific CD4 + and CD8 + T cells and suggests that CD4 + T cells, in particular, play an important role in protection against infection.
DISCUSSION
We used a mouse model of infection with B. pseudomallei to study the role of T cells and IFN-g in protection against primary infection. The results presented here on gene-knockout mice are consistent with those of our previous antibody depletionbased studies in confirming the absolute requirement for IFNg within the first 24 h of infection for the control of bacterial replication [9] . In addition, the results of our studies of IL12p40 Ϫ/Ϫ mice, which lack functional IL-12 and IL-23, suggested that either or both of these cytokines is essential for host resistance. [32, 36, 37] . The rapid in vivo impact of depleting either IFN-g per se or IFN-g-inducing cytokines correlated with the presence of IFN-g-producing spleen cells in infected mice within 16 h of exposure. It is likely that the magnitude of the early splenic IFN-g response to B. pseudomallei infection, which was detected directly ex vivo without the need for in vitro stimulation, was dependent not only on the dose but also on the bacterial strain used, given that different B. pseudomallei strains, which vary in virulence, also vary in the magnitude of cytokine responses they elicit [38] . Early during infection, the dominant source of IFN-g was NK cells, with additional contributions from T cells, NK T cells, and macrophages. In each case, this was strictly dependent in vivo on the cytokines IL-12 and, to a much lesser extent, IL-18. The phenomenon of multicellular sources of early IFN-g has also been reported for Salmonella species [39] , although the cell types responsible differed from those we observed with B. pseudomallei, which perhaps reflects variations in experimental design.
Remarkably, depletion of 95% of the early IFN-g response (by removal of both T and NK cell populations) did not hinder initial bacterial control. Significant redundancy therefore exists between the various cellular sources of innate IFN-g, and the minimum threshold of IFN-g needed for initial bacterial clearance can be attained even in mice deficient in both T and NK cells. These findings clearly show the in vivo importance of other cell types, such as MHC class II int F4/80 + macrophages, which may compensate for the loss of T and NK cells as initial sources of IFN-g during B. pseudomallei infection. This is consistent with other reports of macrophage-derived IFN-g providing early protection against infection with Listeria and Chlamydia species [15, 16, 40] . MHC class II int F4/80 Ϫ cells also produced IFN-g during infection, but the precise lineage of these cells remains unknown. In contrast, Gr1 hi neutrophils and MHC class II hi CD11c + DCs did not produce IFN-g under these conditions. Interestingly, clodronate treatment also severely reduced IFN-g production by NK cells, which suggests that macrophages (but not DCs) play a dual role in the early IFN-g response to B. pseudomallei infection by acting as a source of IFN-g and as an indirect inducer of IFN-g production by other cell types, presumably through the production of IL-12 and IL-18.
We have previously shown in vitro that dead B. pseudomallei organisms induce IFN-g secretion by splenic NK cells and a/ b TCR + T cells. The T cell response was both IL-12 and IL-18 dependent and occurred within 12 h after exposure of previously uninfected spleen cells to the pathogen [23] ; these findings were mirrored by those of the present vivo studies. We and others proposed that IFN-g derived from this cytokinemediated bystander T cell response could contribute to innate resistance against intracellular pathogens [23, 25, 41] . Indeed, the potential protective effects of such cells were seen when they were adoptively transferred into IFN-g Ϫ/Ϫ recipients [41] .
The data presented here, of infection in immunocompetent wild-type (rather than transgenic or knockout) mice, suggest that bystander T cell activation does, indeed, occur in vivo. However, prior depletion of these cells had no effect on initial control of bacterial growth. Therefore, bystander T cell activation, at least for primary melioidosis, is not obligatory for host survival. It is possible, however, that, in other models of infection, bystander T cell-derived IFN-g could constitute a greater proportion of the total IFN-g response and may not be compensated for by other cell types. In contrast to the functional redundancy of bystander T cell responses, we found that antigen-specific T cell responses to B. pseudomallei clearly contributed to resistance against B. pseudomallei during the later phase of infection. We believe that their protective role is directed toward macrophage activation rather than toward B cell help, given that B cell-deficient mMT mice had MSTs that were equivalent to those of wild-type control mice. Although antibody can clearly be protective against B. pseudomallei infection [42, 43] , our data demonstrate that it is not essential for primary resistance.
Considerable effort is now being focused on the generation of vaccination and immunotherapeutic approaches to reduce the incidence of melioidosis in countries where this infection is endemic and to protect against potential bioterrorism exposure. Mouse models of melioidosis will be critical for the determination of appropriate vaccination strategies, antigen discovery, and preclinical testing of candidate vaccines. The data presented here define, for the first time (to our knowledge), the role of T cell-mediated immunity in this model. Our results suggest that safe and effective subunit vaccines against B. pseudomallei should target the generation of IFN-g-secreting T cells for optimal protection against this important disease.
